Ulocuplumab (BMS-936564), a human monoclonal antibody against CXCR4, and MSX-122, a small molecule inhibitor with partial agonist properties that modulates tumour cell migration without altering normal haematopoiesis, are other investigational CXCR4 antagonists [113]. The gene discussed is CXCR4; the disease is neoplasm.